Lipiecki Janusz, Monzy Séverine, Durel Nicolas, Cachin Florent, Chabrot Pascal, Muliez Aurelien, Morand Dominique, Maublant Jean, Ponsonnaille Jean
Department of Cardiology, G. Montpied University Hospital, Clermont-Ferrand, France.
Am Heart J. 2009 Mar;157(3):583.e1-7. doi: 10.1016/j.ahj.2008.11.017. Epub 2009 Feb 4.
Thrombus aspiration devices have been shown to improve reperfusion criteria and to reduce distal embolization in patients treated by percutaneous coronary interventions (PCI) in the acute phase of ST-elevation myocardial infarction (STEMI). There are, however, little data about their efficacy in the reduction of infarct size.
We sought to assess in a prospective randomized trial the impact of thrombus aspiration on infarct size and severity and on left ventricular function in high-risk patients with a first STEMI. The primary end point was scintigraphic infarct size, and secondary end points were infarct severity and regional and global left ventricular function. Forty-four patients with completely occluded (Thrombolysis in Myocardial Infarction flow 0-1) proximal segments of infarct-related artery were randomly assigned to thrombus aspiration group with the Export catheter (n = 20) (Medtronic, Inc, Minneapolis, MN) or PCI-only group. A rest Tc-99-mibi gated single-photon emission computed tomographic and contrast-enhanced magnetic resonance imaging were performed 6 +/- 2 days later.
Infarct size was comparable in patients in the thrombus aspiration group and PCI-only group (30.6% +/- 15.8% vs 28.5% +/- 17.9% of the left ventricle, P = .7) as was infarct severity in infarct-related artery territory (55% +/- 12% vs 55% +/- 14%, P = .9). Transmurality score as assessed by magnetic resonance imaging was similar in both groups (2.03 +/- 1.05 vs 2.16 +/- 1.21, P = .7). There was no impact of thrombus aspiration on other secondary end points.
In our study, thrombus aspiration with the Export catheter performed as adjunctive therapy in high-risk patients with total occlusion of the proximal part of major coronary arteries does not decrease infarct size or severity and has no effect on left ventricular regional and global function.
在ST段抬高型心肌梗死(STEMI)急性期接受经皮冠状动脉介入治疗(PCI)的患者中,血栓抽吸装置已被证明可改善再灌注标准并减少远端栓塞。然而,关于其在减小梗死面积方面的疗效数据很少。
我们试图在一项前瞻性随机试验中评估血栓抽吸对首次发生STEMI的高危患者梗死面积、严重程度及左心室功能的影响。主要终点是闪烁显像梗死面积,次要终点是梗死严重程度以及左心室局部和整体功能。44例梗死相关动脉近端节段完全闭塞(心肌梗死溶栓分级血流0 - 1级)的患者被随机分为使用Export导管的血栓抽吸组(n = 20)(美敦力公司,明尼阿波利斯,明尼苏达州)或单纯PCI组。6±2天后进行静息Tc - 99m铊门控单光子发射计算机断层扫描和对比增强磁共振成像。
血栓抽吸组和单纯PCI组患者的梗死面积相当(分别为左心室的30.6%±15.8%和28.5%±17.9%,P = 0.7),梗死相关动脉区域的梗死严重程度也相当(55%±12%和55%±14%,P = 0.9)。通过磁共振成像评估的透壁性评分在两组中相似(2.03±1.05和2.16±1.21,P = 0.7)。血栓抽吸对其他次要终点无影响。
在我们的研究中,对于主要冠状动脉近端完全闭塞的高危患者,使用Export导管进行血栓抽吸作为辅助治疗并不能减小梗死面积或严重程度,对左心室局部和整体功能也无影响。